VANCOUVER, British Columbia, Canada, Nov. 12, 2003 (PRIMEZONE) -- ProtoKinetix Inc. (OTCBB:PKTX) -- In conjunction with PKTX recent collaboration announcements, Dr. Jean-Marie Dupuy has honored the company with acceptance of a position on their Scientific Advisory Board. Dr. Dupuy is a world recognized medical scientist who was the past Medical Director of Pasteur Merieux Connaught in France. As his Professional Resume is far too extensive to include in this news release, we will post it on the company's developing web site at www.protokinetix.com.
Dr. Jean-Marie Dupuy was instrumental in arranging the validation trials at the Georges Pompidou Hospital in Paris, France. Jean-Marie is currently a consultant to several large pharmaceutical and biotech companies for project development, scientific advice, pre-clinical and clinical research, clinical trial implementation and regulatory agency assistance in the U.S.A., Canada and Europe. He is also author or co-author of more than 240 original scientific and medical articles, communications and books.
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company's filings with the Securities and Exchange Commission.
On behalf of the Board of Directors, Dr. John Todd, President